These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9875438)

  • 1. Biochemical and pharmacological properties of a new proton pump inhibitor, 2-amino-4,5-dihydropyrido[1,2-a]thiazolo [5,4-g] benzimidazole (YJA20379-5).
    Sohn SK; Chang MS; Chung YK; Kim KB; Wook TW; Kim SG; Choi WS
    Arch Pharm Res; 1998 Jun; 21(3):241-7. PubMed ID: 9875438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biochemical and pharmacological properties of a newly synthesized H+-K+ ATPase inhibitor, 2-dimethylamino-4,5-dihydrothiazolo[4,5:3,4]pyridol-[1,2-a]benzimidazol e.
    Chung YK; Chang MS; Kim KB; Sohn SK; Woo TW; Lee SB; Choi WS
    Can J Physiol Pharmacol; 1998 Sep; 76(9):921-9. PubMed ID: 10066143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
    Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
    J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and pharmacological characteristics of a newly synthesized H+-K+ ATPase inhibitor, YJA20379-1, 2-amino-4,5-dihydro-8-phenylimidazole[2,1-b]thiazolo[5,4-g]benzothiazol e.
    Sohn SK; Chang MS; Choi WS; Kim KB; Woo TW; Lee SB; Chung YK
    Can J Physiol Pharmacol; 1999 May; 77(5):330-8. PubMed ID: 10535682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
    Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
    Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and pharmacological characteristics of a newly synthesized H+/K+-ATPase inhibitor, YJA20379-8, 3-butyryl-4-[R-1-methylbenzylamino]-8-ethoxy-1,7-naphthyridine, in pigs and rats.
    Sohn SK; Chang MS; Choi WS; Chung YK; Kim KB; Woo TW; Lee SB; Park CJ
    J Pharm Pharmacol; 1999 Dec; 51(12):1359-65. PubMed ID: 10678489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats.
    Woo TW; Chang MS; Chung YK; Kim KB; Sohn SK; Kim SG; Choi WS
    Biol Pharm Bull; 1998 May; 21(5):449-55. PubMed ID: 9635498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and pharmacological analysis of 2-[(2-dimethylaminobenzyl)sulfinyl] benzimidazole (NC-1300), a new proton pump inhibitor.
    Okabe S; Higaki E; Higuchi T; Sato M; Hara K
    Jpn J Pharmacol; 1986 Feb; 40(2):239-49. PubMed ID: 3009944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric antisecretory and anti-ulcer effect of ME3407, a new benzimidazole derivative, in rats.
    Tanaka J; Iida H; Abe M; Yuda Y; Inoue S; Okabe S
    Arzneimittelforschung; 2004; 54(4):221-9. PubMed ID: 15146935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NC-1300-B, a new benzimidazole derivative, on hog gastric H+, K+-ATPase, gastric acid secretion and HCl.ethanol-induced gastric lesions in rats.
    Okabe S; Akimoto Y; Yamasaki S; Nagai H
    Dig Dis Sci; 1988 Nov; 33(11):1425-34. PubMed ID: 2846250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
    Kinoshita M; Saito N; Tamaki H
    Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats.
    Yamamoto O; Okada Y; Okabe S
    Dig Dis Sci; 1984 May; 29(5):394-401. PubMed ID: 6714055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a new benzimidazole derivative, NC-1300-O-3, on gastric secretion and gastroduodenal lesions in rats.
    Okabe S; Akimoto Y; Yamasaki S; Kuwahara K
    Jpn J Pharmacol; 1991 Apr; 55(4):477-91. PubMed ID: 1832198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
    Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
    J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion and gastroduodenal ulcers in rats.
    Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
    Methods Find Exp Clin Pharmacol; 1999 Mar; 21(2):115-22. PubMed ID: 10327392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroprotective effect of Neem (Azadirachta indica) bark extract: possible involvement of H(+)-K(+)-ATPase inhibition and scavenging of hydroxyl radical.
    Bandyopadhyay U; Biswas K; Chatterjee R; Bandyopadhyay D; Chattopadhyay I; Ganguly CK; Chakraborty T; Bhattacharya K; Banerjee RK
    Life Sci; 2002 Nov; 71(24):2845-65. PubMed ID: 12377267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.